Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection.
暂无分享,去创建一个
[1] B. Bonavida,et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.
[2] S. Horvath,et al. Expression of transcription factor Yin Yang 1 in prostate cancer. , 2005, International journal of oncology.
[3] R. Kraft,et al. Caspase-Dependent Regulation and Subcellular Redistribution of the Transcriptional Modulator YY1 during Apoptosis , 2005, Molecular and Cellular Biology.
[4] D. Spandidos,et al. VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. , 2005, Cancer letters.
[5] Napoleone Ferrara,et al. Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.
[6] C. Heldin,et al. Nuclear Factor YY1 Inhibits Transforming Growth Factor β- and Bone Morphogenetic Protein-Induced Cell Differentiation , 2003, Molecular and Cellular Biology.
[7] Kwangmoon Lee,et al. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. , 2002, International journal of radiation oncology, biology, physics.
[8] C. Heldin,et al. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. , 2002, Immunology letters.
[9] L. Khachigian,et al. Induction of the Transcriptional Repressor Yin Yang-1 by Vascular Cell Injury , 2001, The Journal of Biological Chemistry.
[10] G. Fleuren,et al. Cytokine profile of cervical cancer cells. , 2001, Gynecologic oncology.
[11] T. Out,et al. Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. , 2001, Cytokine.
[12] P. Tighe,et al. Decreased synthesis and expression of TGF‐β1, β2, and β3 in epithelium of HPV 16‐positive cervical precancer: a study by microdissection, quantitative RT‐PCR, and immunocytochemistry , 2000 .
[13] Chien-Nan Lee,et al. Vascular Endothelial Growth Factor and Prognosis of Cervical Carcinoma , 2000, Obstetrics and gynecology.
[14] B. Weyn,et al. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer. , 2000, European journal of obstetrics, gynecology, and reproductive biology.
[15] H. Ngan,et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. , 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[16] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[17] D. Spandidos,et al. High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears. , 1999, Oncology reports.
[18] Yang Shi,et al. Targeted Disruption of Mouse Yin Yang 1 Transcription Factor Results in Peri-Implantation Lethality , 1999, Molecular and Cellular Biology.
[19] E. Seto,et al. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.
[20] H. Pfister,et al. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16. , 1999, The Journal of general virology.
[21] C. N. Lee,et al. Vascular endothelial growth factor in cervical carcinoma. , 1999, Obstetrics and gynecology.
[22] D. Sherer,et al. Angiogenesis in malignancies of the female genital tract. , 1999, Gynecologic oncology.
[23] M. Klinnert,et al. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma , 1998 .
[24] D. Spandidos,et al. Detection of HPV and ras gene mutations in cervical smears from female genital lesions. , 1998, Oncology reports.
[25] P. Delvenne,et al. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression , 1998, Clinical and experimental immunology.
[26] B. Rose,et al. Point mutations in SP1 motifs in the upstream regulatory region of human papillomavirus type 18 isolates from cervical cancers increase promoter activity. , 1998, The Journal of general virology.
[27] Anita B. Roberts,et al. REGULATION OF IMMUNE RESPONSES BY TGF-β* , 1998 .
[28] A. Kaider,et al. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. , 1997, Journal of the National Cancer Institute.
[29] Jeng-Shin Lee,et al. Everything you have ever wanted to know about Yin Yang 1...... , 1997, Biochimica et biophysica acta.
[30] G. Parham,et al. Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. , 1997, Gynecologic oncology.
[31] Bernhard Lüscher,et al. Characterization of the Transcriptional Regulator YY1 , 1997, The Journal of Biological Chemistry.
[32] K. Flanders,et al. Altered expression of transforming growth factor‐β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix , 1996, Cancer.
[33] Anthony J. Guidi,et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. , 1995, Journal of the National Cancer Institute.
[34] J. Flanagan. Autologous stimulation of YY1 transcription factor expression: role of an insulin-like growth factor. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[35] G. Trinchieri,et al. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. , 1994, Journal of immunology.
[36] F. Stubenrauch,et al. Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers , 1994, International journal of cancer.
[37] F. Hoppe-Seyler,et al. Cellular control of human papillomavirus oncogene transcription , 1994, Molecular carcinogenesis.
[38] S. Wahl,et al. Transforming growth factor β : a matter of life and death , 1994 .
[39] K. Smith-McCune,et al. Demonstration and characterization of the angiogenic properties of cervical dysplasia. , 1994, Cancer research.
[40] K. Münger,et al. The human papillomavirus E7 protein as a transforming and transactivating factor. , 1993, Biochimica et biophysica acta.
[41] R. Schlegel,et al. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18 , 1991, Journal of virology.
[42] R. Schlegel,et al. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. , 1991, Virology.
[43] M. Sporn,et al. Deactivation of macrophages by transforming growth factor-β , 1988, Nature.
[44] A. Ammann,et al. Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta. , 1988, Cellular immunology.
[45] D. Spandidos,et al. Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. , 2005, The International journal of biological markers.
[46] L. Palmer,et al. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. , 2004, American journal of respiratory and critical care medicine.
[47] A. Balmain,et al. TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.
[48] P. Tighe,et al. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry. , 2000, The Journal of pathology.
[49] T. Spector,et al. Genetic control of the circulating concentration of transforming growth factor type beta1. , 1999, Human molecular genetics.
[50] A. Roberts,et al. Regulation of immune responses by TGF-beta. , 1998, Annual review of immunology.
[51] S. Wahl,et al. Transforming growth factor beta: a matter of life and death. , 1994, Journal of leukocyte biology.
[52] M. Sporn,et al. Deactivation of macrophages by transforming growth factor-beta. , 1988, Nature.